PoreSpect
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 6
About PoreSpect
, trading as PoreSpect, operates as a biotechnology company dedicated to providing solid-state nanopore detection equipment. It was jointly founded by PhDs from Stanford University and Imperial College of Technology. The company mainly develops biomacromolecule detection equipment, gene sequencers, and supporting reagent consumables based on solid-state nanopore single-molecule detection technology. The main product is solid-state nanopore detection equipment. The company's revenue is generated by providing biomacromolecule detection equipment and gene sequencers.
Who invested in PoreSpect
6 investors across 2 rounds
See all investors in PoreSpect
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PoreSpect
Who invested in PoreSpect?
PoreSpect has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PoreSpect raised?
PoreSpect has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PoreSpect last raise money?
PoreSpect's most recent round on record is a Series A, in Jan 2026.
What does PoreSpect do?
, trading as PoreSpect, operates as a biotechnology company dedicated to providing solid-state nanopore detection equipment.
Where is PoreSpect headquartered?
PoreSpect is headquartered in Guangzhou, China.
Which VCs invest in companies like PoreSpect?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at PoreSpect's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like PoreSpect? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.